BRPI0808522A8 - Uso de lactobacillus plantarum para aumentar diversidade bacterial - Google Patents

Uso de lactobacillus plantarum para aumentar diversidade bacterial

Info

Publication number
BRPI0808522A8
BRPI0808522A8 BRPI0808522A BRPI0808522A BRPI0808522A8 BR PI0808522 A8 BRPI0808522 A8 BR PI0808522A8 BR PI0808522 A BRPI0808522 A BR PI0808522A BR PI0808522 A BRPI0808522 A BR PI0808522A BR PI0808522 A8 BRPI0808522 A8 BR PI0808522A8
Authority
BR
Brazil
Prior art keywords
diversity
individual
lactobacillus plantarum
strain
sibo
Prior art date
Application number
BRPI0808522A
Other languages
English (en)
Inventor
Molin Göran
Ahrne Siv
Karlsson Caroline
Jeppsson Bengt
Original Assignee
Probi Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probi Ab filed Critical Probi Ab
Publication of BRPI0808522A2 publication Critical patent/BRPI0808522A2/pt
Publication of BRPI0808522A8 publication Critical patent/BRPI0808522A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/169—Plantarum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

USO DE LACTOBACILLUS PARA AUMENTAR DIVERSIDADE BACTERIAL. A presente invenção refere-se ao uso de uma cepa de Lactobacillus plantarum para a manufatura de uma composição para aumentar a diversidade do trato gastrointestinal por administração de referida cepa a um indivíduo com uma visão de produção de uma diferença de Índice de diversidade aumentada comparada ao placebo é descrito, bem como uso de uma cepa de Lactobacillus plantarum para a manufatura de uma composição para tratamento profilático de um indivíduo saudável contra desenvolvimento de uma diversidade bacterial baixa (LBD); de um individuo tendo LBD contra desenvolvimento de uma ou mais condições fisiologicamente perturbadas, crescimento excessivo bacterial do intestino grosso (LIBO) ou crescimento excessivo bacterial do intestino delgado (SIBO); e de um indivíduo tendo LIBO ou SIBO contra desenvolvimento de uma ou mais condições fisiologicamente perturbadas, e um método para aumentar a referida diversidade
BRPI0808522A 2007-03-01 2008-02-29 Uso de lactobacillus plantarum para aumentar diversidade bacterial BRPI0808522A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0700551 2007-03-01
PCT/SE2008/000170 WO2008105715A2 (en) 2007-03-01 2008-02-29 Use of lactobacillus plantarum for increasing bacterial diversity

Publications (2)

Publication Number Publication Date
BRPI0808522A2 BRPI0808522A2 (pt) 2015-02-10
BRPI0808522A8 true BRPI0808522A8 (pt) 2017-10-10

Family

ID=39673143

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0808522A BRPI0808522A8 (pt) 2007-03-01 2008-02-29 Uso de lactobacillus plantarum para aumentar diversidade bacterial

Country Status (19)

Country Link
US (1) US8586026B2 (pt)
EP (1) EP2136825B1 (pt)
JP (2) JP5829005B2 (pt)
KR (1) KR101510691B1 (pt)
CN (1) CN101674840B (pt)
AU (1) AU2008219818B2 (pt)
BR (1) BRPI0808522A8 (pt)
CA (1) CA2679480C (pt)
CY (1) CY1115089T1 (pt)
DK (1) DK2136825T3 (pt)
ES (1) ES2446942T3 (pt)
HR (1) HRP20140080T1 (pt)
NZ (1) NZ579330A (pt)
PL (1) PL2136825T3 (pt)
PT (1) PT2136825E (pt)
RU (1) RU2521364C2 (pt)
SI (1) SI2136825T1 (pt)
WO (1) WO2008105715A2 (pt)
ZA (1) ZA200906534B (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
HK1253538A1 (en) * 2010-08-04 2019-06-21 Thomas Julius Borody Compositions for fecal floral transplantation and methods for making and using them
EP3424515A3 (en) 2010-08-04 2019-06-19 Thomas Julius Borody Stool collection devices and methods for using them
US9968638B2 (en) 2011-03-09 2018-05-15 Regents Of The University Of Minnesota Compositions and methods for transplantation of colon microbiota
US9719144B2 (en) 2012-05-25 2017-08-01 Arizona Board Of Regents Microbiome markers and therapies for autism spectrum disorders
BR112017024264B1 (pt) 2015-05-14 2022-07-12 Crestovo Holdings Llc Composições para transplante de flora fecal e métodos de preparação e utilização das mesmas, e dispositivos para sua administração
KR102534545B1 (ko) 2015-05-22 2023-05-18 아리조나 보드 오브 리젠츠 온 비하프 오브 아리조나 스테이트 유니버시티 자폐 스펙트럼 장애 및 관련된 증상을 치료하는 방법
US20170360848A1 (en) 2016-06-15 2017-12-21 Arizona Board Of Regents On Behalf Of Arizona State University Methods for treating autism spectrum disorder and associated symptoms
US10849936B2 (en) 2016-07-01 2020-12-01 Regents Of The University Of Minnesota Compositions and methods for C. difficile treatment
US20180036352A1 (en) 2016-08-03 2018-02-08 Crestovo Holdings Llc Methods for treating ulcerative colitis
RU2628063C1 (ru) * 2016-09-22 2017-08-14 федеральное государственное бюджетное образовательное учреждение высшего образования "Тюменский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО Тюменский ГМУ Минздрава России) Способ прогнозирования транслокации E.coli из кишечника при некультивируемом типе инфекционного процесса в эксперименте на кроликах
RU2642327C1 (ru) * 2016-10-06 2018-01-24 федеральное государственное бюджетное образовательное учреждение высшего образования "Тюменский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО Тюменский ГМУ Минздрава России) Способ прогноза развития патогенетического процесса по некультивируемому или культивируемому типу в эксперименте
WO2018071536A1 (en) 2016-10-11 2018-04-19 Crestovo Holdings Llc Compositions and methods for treating primary sclerosing cholangitis and related disorders
WO2018071537A1 (en) 2016-10-11 2018-04-19 Crestovo Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
US10092601B2 (en) 2016-10-11 2018-10-09 Crestovo Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
EP3606541A1 (en) 2017-04-05 2020-02-12 Crestovo Holdings LLC Compositions and methods for treating parkinson's disease (pd) and related disorders
US11040073B2 (en) 2017-04-05 2021-06-22 Finch Therapeutics Holdings Llc Compositions and methods for treating diverticulitis and related disorders
JP2020521760A (ja) 2017-05-26 2020-07-27 クレストヴォ・ホールディングス・エルエルシー 糞便微生物ベースの治療剤を含む凍結乾燥組成物ならびにそれを製造および使用する方法
GB201709763D0 (en) * 2017-06-19 2017-08-02 Probi Ab Biological materials and methods
JP2020530494A (ja) 2017-08-07 2020-10-22 フィンチ セラピューティクス、インコーポレイテッド． 健康な腸バリアを維持及び回復するための組成物及び方法
WO2019215223A1 (en) * 2018-05-08 2019-11-14 F. Hoffmann-La Roche Ag Method of cancer prognosis by assessing tumor variant diversity by means of establishing diversity indices
US11166990B2 (en) 2018-07-13 2021-11-09 Finch Therapeutics Holdings Llc Methods and compositions for treating ulcerative colitis
TWI706783B (zh) * 2018-07-18 2020-10-11 大江生醫股份有限公司 延緩老化之益生菌株及其組合物與用途
EP3856212A1 (en) 2018-09-27 2021-08-04 Finch Therapeutics Holdings LLC Compositions and methods for treating epilepsy and related disorders
PH12021553137A1 (en) 2019-07-19 2022-07-25 Finch Therapeutics Holdings Llc Methods and products for treatment of gastrointestinal disorders
AU2020405028B2 (en) 2019-12-17 2023-11-09 Metagenics LLC Multi-strain probiotic composition and its use
BR112022014252A2 (pt) * 2020-01-23 2022-09-20 Gervais Danone Sa Processo para a preparação de uma composição fermentada à base de plantas, composição à base de plantas e composição fermentada à base de plantas
FR3122084B1 (fr) 2021-04-21 2023-10-27 Mirei Int Ltd Composition cosmétique ou pharmaceutique caractérisée par une association de bioactifs sélectionnés à partir de graines deGlycine max pour son utilisation dans la modulation du microbiote intestinal et cutanée et l’équilibre de l’axe intestin-peau-cerveau.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE469875C (sv) * 1991-07-25 1997-04-14 Probi Ab Stam av tarmkoloniserande Lactobacillus samt komposition för profylax eller behandling av infektioner i magtarmkanalen
JPH092959A (ja) * 1995-06-16 1997-01-07 Yakult Honsha Co Ltd ＩｇＥ抗体産生抑制剤および抗アレルギー剤
RU2247148C2 (ru) * 2002-05-28 2005-02-27 Пименов Евгений Васильевич Штамм бактерий lactobacillus plantarum p4, штамм бактерий lactobacillus buchneri p0 и препарат-пробиотик на их основе для коррекции дисбактериозов различной этиологии у людей и животных
SE527555C2 (sv) * 2003-04-04 2006-04-11 Probi Ab Anti-inflammatorisk komposition innehållande tannasproducerande Lactobacillusstammar
US20060093592A1 (en) 2004-10-04 2006-05-04 Nutracea Synbiotics
SE528382C2 (sv) 2004-10-05 2006-10-31 Probi Ab Probiotiska lactobacillusstammar för förbättrad vaginal hälsa
JP4320408B2 (ja) * 2005-04-21 2009-08-26 学校法人明治大学 胆汁酸結合能を有する新規菌株
GB0513556D0 (en) 2005-07-01 2005-08-10 Matforsk As Product
SE529199C2 (sv) * 2005-07-05 2007-05-29 Probi Ab Förstärkt absorption

Also Published As

Publication number Publication date
SI2136825T1 (sl) 2014-04-30
EP2136825A2 (en) 2009-12-30
RU2521364C2 (ru) 2014-06-27
PL2136825T3 (pl) 2014-04-30
WO2008105715A3 (en) 2008-10-30
US8586026B2 (en) 2013-11-19
US20100143463A1 (en) 2010-06-10
KR20090127415A (ko) 2009-12-11
CN101674840B (zh) 2014-05-21
DK2136825T3 (da) 2014-02-24
ES2446942T3 (es) 2014-03-10
BRPI0808522A2 (pt) 2015-02-10
CY1115089T1 (el) 2016-12-14
CN101674840A (zh) 2010-03-17
AU2008219818B2 (en) 2013-06-27
KR101510691B1 (ko) 2015-04-10
AU2008219818A1 (en) 2008-09-04
PT2136825E (pt) 2014-02-21
NZ579330A (en) 2012-02-24
ZA200906534B (en) 2010-11-24
JP6162749B2 (ja) 2017-07-12
HRP20140080T1 (hr) 2014-03-14
EP2136825B1 (en) 2013-11-20
RU2009136328A (ru) 2011-04-10
CA2679480C (en) 2016-10-18
WO2008105715A2 (en) 2008-09-04
JP5829005B2 (ja) 2015-12-09
JP2010520234A (ja) 2010-06-10
CA2679480A1 (en) 2008-09-04
JP2015164952A (ja) 2015-09-17

Similar Documents

Publication Publication Date Title
BRPI0808522A8 (pt) Uso de lactobacillus plantarum para aumentar diversidade bacterial
BR112014013786A2 (pt) método para ventilação de um indivíduo, método para rapidamente ventilar um indivíduo que apresenta desconforto respiratório, e, dispositivo para ventilação de um indivíduo através de uma ou mais passagens do corpo
NZ745678A (en) Compositions comprising bacterial blautia strains for treating visceral hypersensitivity
BR112012001353B8 (pt) anel vaginal, e, método para fabricar um anel vaginal
CY1120807T1 (el) Συνθεσεις και μεθοδοι για την τροποποιηση της smn2 συναρμογης σε ενα υποκειμενο
BR112013016914A2 (pt) combinação simbiótica de probióticos e oligossacarídeos do leite humano para promover o crescimento de microbiota benéfica
EA201390305A1 (ru) Композиции для влагалищного и перорального введения lactobacillus и их применение
CL2008000928A1 (es) Uso de bacterias probioticas de las especies lactobacillus rhamnosus, cepas atcc 53103 ó cgmcc 13724 para la fabaricacion de un medicamento o formula infantil que permite reducir el riesgo de que el infante desarrolle obesidad a lo largo de su vida.
BRPI0616962B8 (pt) uso de lactobacillus para o tratamento de doenças autoimunes
UA96744C2 (ru) Композиция штаммов рода lactobacillus и применение композиции штаммов рода lactobacillus
BR112013019258A8 (pt) Uso de uma formulação probiótica compreendendo uma cepa de bifidobacterium bifidum
BR112014025469A2 (pt) uso de bactérias probióticas no tratamento de infecções bacterianas e regeneração da pele, bem como composições compreendendo cepas das referidas bactérias
BR112012007109A2 (pt) bifidobacterium longum atcc baa-999 (bl-999) e controle de peso
UY31228A1 (es) Ariloxazoles sustituidos y su uso
CA2713943C (en) Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof
WO2019066577A3 (ko) 짧은 사슬 지방산 생성 장내 세균 군집의 변화를 이용한 알코올성 간 질환의 진단 및 치료용 조성물
UY31310A1 (es) Ácidos 6-fenilnicotínicos sustituidos y su uso
CL2011000099A1 (es) Uso de una beta-defensina humana en la manufactura de un medicamento que sirve para el tratamiento de una enfermedad intestinal inflamatoria.
BR112017023636A2 (pt) suplemento dietético
BR112012017300A2 (pt) processo de para preparação de uma biomassa compreendendo plantaricina e usos da mesma no campo médico
WO2008016666A3 (en) Certain chemical entities, compositions, and methods
BR112016025481A2 (pt) alimentos, sistemas, métodos e estojos para provisão de substituição de eletrólito
WO2010116088A3 (fr) Dérivés de quinazolinedione, leur préparation et leurs diverses applications thérapeutiques
WO2010115034A3 (en) Protein biomarkers for soft tissue disease diagnosis and as therapeutic targets for oral care intervention
WO2011080396A3 (en) Probiotic bifidobacterial composition in accordance with secretor blood group status

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61K 35/747 (2015.01), A61P 1/00 (2000.01)

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]